127 related articles for article (PubMed ID: 3544033)
1. Posttransplantation cyclosporine-induced lymphoproliferative disorders: clinical and radiologic manifestations.
Harris KM; Schwartz ML; Slasky BS; Nalesnik M; Makowka L
Radiology; 1987 Mar; 162(3):697-700. PubMed ID: 3544033
[TBL] [Abstract][Full Text] [Related]
2. Clinical and radiologic features of malignant neoplasms in organ transplant recipients: cyclosporine-treated vs untreated patients.
Honda H; Barloon TJ; Franken EA; Garneau RA; Smith JL
AJR Am J Roentgenol; 1990 Feb; 154(2):271-4. PubMed ID: 2105012
[TBL] [Abstract][Full Text] [Related]
3. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.
Starzl TE; Nalesnik MA; Porter KA; Ho M; Iwatsuki S; Griffith BP; Rosenthal JT; Hakala TR; Shaw BW; Hardesty RL
Lancet; 1984 Mar; 1(8377):583-7. PubMed ID: 6142304
[TBL] [Abstract][Full Text] [Related]
4. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
[TBL] [Abstract][Full Text] [Related]
5. Posttransplantation lymphoproliferative disorder in pediatric recipients of solid organ transplants: timing and location of disease.
Wilde GE; Moore DJ; Bellah RD
AJR Am J Roentgenol; 2005 Nov; 185(5):1335-41. PubMed ID: 16247159
[TBL] [Abstract][Full Text] [Related]
6. Lymphoproliferative disorders and hematologic malignancies following organ transplantation.
Ferry JA; Jacobson JO; Conti D; Delmonico F; Harris NL
Mod Pathol; 1989 Nov; 2(6):583-92. PubMed ID: 2587566
[TBL] [Abstract][Full Text] [Related]
7. Chest radiography as a predictor of outcome in posttransplantation lymphoproliferative disorder in lung allograft recipients.
Pickhardt PJ; Siegel MJ; Anderson DC; Hayashi R; DeBaun MR
AJR Am J Roentgenol; 1998 Aug; 171(2):375-82. PubMed ID: 9694455
[TBL] [Abstract][Full Text] [Related]
8. CT of posttransplantation lymphoproliferative disorder in pediatric recipients of lung allograft.
Siegel MJ; Lee EY; Sweet SC; Hildebolt C
AJR Am J Roentgenol; 2003 Oct; 181(4):1125-31. PubMed ID: 14500243
[TBL] [Abstract][Full Text] [Related]
9. Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy.
Beveridge T; Krupp P; McKibbin C
Lancet; 1984 Apr; 1(8380):788. PubMed ID: 6143097
[No Abstract] [Full Text] [Related]
10. Cyclosporine: a new immunosuppressive agent for organ transplantation.
Cohen DJ; Loertscher R; Rubin MF; Tilney NL; Carpenter CB; Strom TB
Ann Intern Med; 1984 Nov; 101(5):667-82. PubMed ID: 6385799
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine immunosuppression.
Canafax DM; Ascher NL
Clin Pharm; 1983; 2(6):515-24. PubMed ID: 6360494
[TBL] [Abstract][Full Text] [Related]
12. [Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases].
Guerci AP; Burtin P; Mattei S; Lederlin P
Ann Med Interne (Paris); 1992; 143(3):155-9. PubMed ID: 1524349
[TBL] [Abstract][Full Text] [Related]
13. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant.
Chadburn A; Chen JM; Hsu DT; Frizzera G; Cesarman E; Garrett TJ; Mears JG; Zangwill SD; Addonizio LJ; Michler RE; Knowles DM
Cancer; 1998 May; 82(10):1978-87. PubMed ID: 9587133
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine in cardiac transplantation.
Goldman MH; Barnhart G; Mohanakumar T; Wetstein L; Szentpetery S; Wolfgang TC; Lower RR
Surg Clin North Am; 1985 Jun; 65(3):637-59. PubMed ID: 3898434
[TBL] [Abstract][Full Text] [Related]
15. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
[TBL] [Abstract][Full Text] [Related]
16. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.
Nalesnik MA; Jaffe R; Starzl TE; Demetris AJ; Porter K; Burnham JA; Makowka L; Ho M; Locker J
Am J Pathol; 1988 Oct; 133(1):173-92. PubMed ID: 2845789
[TBL] [Abstract][Full Text] [Related]
17. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression.
Armitage JM; Kormos RL; Stuart RS; Fricker FJ; Griffith BP; Nalesnik M; Hardesty RL; Dummer JS
J Heart Lung Transplant; 1991; 10(6):877-86; discussion 886-7. PubMed ID: 1661607
[TBL] [Abstract][Full Text] [Related]
18. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
Muchtar E; Kramer MR; Vidal L; Ram R; Gurion R; Rosenblat Y; Bakal I; Shpilberg O
Transplantation; 2013 Oct; 96(7):657-63. PubMed ID: 23823652
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine in cardiac transplantation.
Devineni R; McKenzie N; Keown P; Kostuk W; Stiller C; Silver M
Can J Surg; 1984 May; 27(3):252-4. PubMed ID: 6232993
[TBL] [Abstract][Full Text] [Related]
20. Lymphoproliferative disorder of nasopharynx after long-standing cyclosporin therapy for psoriatic arthritis.
Leong AC; Yong J; Salama N
J Laryngol Otol; 2010 Oct; 124(10):1120-2. PubMed ID: 20370953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
